This study found that FA, but not other classes of NSAIDs, ameliorates the activation of the microglial NLRP3 inflammasome, thereby effectively reducing neuropathological hallmarks of AD and restoring memory deficit. Here, NLRP3 is linked to Alzheimer disease.